These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 11158049)

  • 1. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
    J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(5):e96482. PubMed ID: 24788417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
    J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
    Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
    Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.
    Kasim-Karakas SE; Herrmann R; Almario R
    Metabolism; 1995 Sep; 44(9):1223-30. PubMed ID: 7666799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man.
    Nicoll A; Lewis B
    Eur J Clin Invest; 1980 Dec; 10(6):487-95. PubMed ID: 6788567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study.
    Garenc C; Pérusse L; Gagnon J; Chagnon YC; Bergeron J; Després JP; Province MA; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C
    Metabolism; 2000 Apr; 49(4):432-9. PubMed ID: 10778864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.
    Ooi EM; Russell BS; Olson E; Sun SZ; Diffenderfer MR; Lichtenstein AH; Keilson L; Barrett PH; Schaefer EJ; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):459-66. PubMed ID: 22095987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes.
    Pruneta-Deloche V; Sassolas A; Dallinga-Thie GM; Berthezène F; Ponsin G; Moulin P
    J Lipid Res; 2004 May; 45(5):859-65. PubMed ID: 14967813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
    Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.
    Miyazaki O; Fukamachi I; Mori A; Hashimoto H; Kawashiri MA; Nohara A; Noguchi T; Inazu A; Yamagishi M; Mabuchi H; Kobayashi J
    Biochem Biophys Res Commun; 2009 Jan; 379(1):55-9. PubMed ID: 19070596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
    Jong MC; Dahlmans VE; Hofker MH; Havekes LM
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
    Ćwiklińska A; Cackowska M; Wieczorek E; Król E; Kowalski R; Kuchta A; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Zielińska J; Dębska-Ślizień A; Jankowski M
    Kidney Blood Press Res; 2018; 43(3):970-978. PubMed ID: 29913451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency.
    Garenc C; Couillard C; Laflamme N; Cadelis F; Gagné C; Couture P; Julien P; Bergeron J
    Eur J Hum Genet; 2005 Oct; 13(10):1159-65. PubMed ID: 16015281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.